期刊文献+

骨形成蛋白与前列腺癌

Bone morphogenetic proteins and prostate carcinoma
下载PDF
导出
摘要 前列腺癌是西方国家男性最常见的恶性肿瘤之一,目前我国前列腺癌的发病率亦明显增加。前列腺和前列腺癌组织中有骨形成蛋白(bone morphogenetic proteins,BMPs)及其受体的表达。BMPs能够诱导异位成骨、细胞趋化、分化和胚胎发育。某些BMPs及其受体在前列腺癌细胞表达,可以作为前列腺癌发生、发展和预后的标志物。BMPs对前列腺癌细胞生物学行为的调控作用是多样的,与肿瘤细胞类型、分化状态和局部微环境有关。BMPs在前列腺癌进展过程中,特别是在促进前列腺癌骨转移并在成骨反应中发挥重要作用。研究BMPs与前列腺癌的关系,有助于阐明前列腺癌的发病及转移机制,为前列腺癌的治疗提供实验依据。 Prostate carcinoma(PC) is one of the most common male malignancies in Western countries,and recently the morbidity of PC have greatly increased in China.Bone morphogenetic proteins(BMPs) and their receptors(BMPRs) are expressed in prostate and PC tissues.BMPs can induce ectopic bone formation,cell chemotaxis,cell differentiation and embryogenesis.Some BMPs and BMPRs are expressed on PC cells and can be used as the prognostic markers for the development,progression and prognosis of PC.BMPs modulate the biological behaviors of PC cells in a diverse manner,depending on the cell type,cell differentiation state and local microenvironment.BMPs also play important roles in the progression of PC,especially in promoting PC metastasis to bone,accompanied by a strong osteoblastic reaction.Study on the relationship between BMPs and PC can help to explain the development and metastasis of PC,and provide a theoretical basis for PC therapy.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2010年第5期584-588,共5页 Chinese Journal of Cancer Biotherapy
关键词 前列腺肿瘤 骨形成蛋白 骨转移 prostate neoplasmas bone morphogenetic protein bone metastasis
  • 相关文献

参考文献32

  • 1Wang H, Noulet F, Edom-Vovard F, Tozer S, Le Grand F, Duprez D. Bmp signaling at the tips of skeletal muscles regulates the number of fetal muscle progenitors and satellite cells during development [J]. Dev Cell, 2010, 18 (4) : 643-654.
  • 2Buijs JT, Petersen M, van der Horst G, van der Pluijm G. Bone morphogenetic proteins and its receptors: Therapeutic targets in cancer progression and bone metastasis [ J ]. Curr Pharm Des, 2010, 16 (11): 1291-1300.
  • 3Horvath LG, Henshall SM, Kench JG, Turner J J, Golovsky D, Brenner PC, etal. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression [ J ]. Prostate, 2004, 59 (3) : 234- 242.
  • 4Doak SH, Jenkins SA, Hurle RA, Varma M, Hawizy A, Kynaston HG, et al. Bone morphogenic factor gene dosage abnormalities in prostatic intraepithelial neoplasia and prostate cancer [ J ]. Cancer Genet Cytogenet, 2007, 176 (2) :161-165.
  • 5Yuen HF, Chan YP, Cheung WL, Wong YC, Wang X, Chan KW. The prognostic significance of BMP-6 signaling in prostate cancer [J]. Mod Pathol, 2008, 21 (12) : 1436-1443.
  • 6Kim IY, Lee DH, Lee DK, Ahn HJ, Kim MM, Kim SJ, et al. Loss of expression of bone mm-phogenetic protein receptor type II in human prostate cancer cells [J]. Oncogene, 2004, 23 (46): 7651-7659.
  • 7Tomari K, Kumagai T, Shimizu T, Takeda K. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells [Jl. Int J Mol Med, 2005, 15 (2) : 253-258.
  • 8Kumagai T, Tomari K, Shimizu T, Takeda K. Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells [ J ]. Int J Mol Med, 2006, 17 (2) : 285-291.
  • 9Miyazaki H, Watabe T, Kitamura T, Miyazono K. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells [ J]. Oncogene, 2004, 23 (58) : 9326-9335.
  • 10Haudenschild DR, Pahner SM, Moseley TA, You Z, Reddi AH. Bone morphogenctic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer [ J ]. Cancer Res, 2004, 64 (22) : 8276 -8284.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部